A study led by the American Cancer Society (ACS) has found that incidence rates for early-onset colorectal cancer, diagnosed in individuals under 50 have increased in 27 of 50 countries examined.
Researchers at the Mayo Clinic have presented data to show that the monoclonal antibody daratumumab, which targets the CD38 protein, significantly reduces the risk of smoldering multiple myeloma (SMM) progressing to active myeloma.
New evidence of a “waste canal system” in the human brain has been uncovered, with implications for Alzheimer's disease.
Before reaching the market, new drugs are tested in people who voluntarily participate in clinical trials. However, for a new medicine to work in as many people as possible, these drugs should be tested in a patient population that is as diverse as possible.
Although this gene-editing technology promises impressive improvements in healthcare, various obstacles must be addressed before large numbers of patients can benefit.
Based on a growing body of data, some experts believe that pharmacogenomics-guided spaceflight is the foundation of precision medicine, a feature that they believe will enable long-term human habitation on the Moon.
In the U.S., pain annually affects 100 million Americans, amounting to half a trillion dollars in terms of economic burden. Still, the opioid epidemic rages on, a major cause for mortality among young adults.
The team identified a panel of 27 proteins as biomarkers of cardiomyopathy risk when measured in blood serum.
The findings support the use of the PARP inhibitor as adjuvant therapy after standard treatments like chemotherapy, surgery, and radiation.
Scientists have taken a step toward patient-specific radiation therapies by repurposing the KRAS G12C inhibitor sotorasib to make it a target for radioactive antibodies when bound to tumor cells.
